SPOTLIGHT -
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Central to the Mission
Harpreet Gill, vice president of real-world solutions - project management at ICON, discussesthe progress and challenges in advancing data-driven tools and approaches in decentralized clinical trials, where ongoing education remains paramount.
What Novo Nordisk’s Purchase of Catalent Means for the Industry
Bruce Phelan of Blue Fin discusses pharma’s need for access to manufacturing sites.
Expected Savings From AI is Impacting Pharma 2024 Budgets: Report
A new survey of pharma executives suggests that many are fully embracing the use of AI and are making financials plans based on the technology’s usage.
BioNTech and Autolus Announce Strategic Alliance to Bolster CAR-T Cell Pipeline
BioNTech will invest $200 million and get access to Autolus’ manufacturing sites.
New Report Says Generic Drug Market Is Set to Grow Over $175 Billion by 2027
According to the study conducted by Technavio, North America will contribute to 37% of the expected growth.
Pfizer Teams With American Cancer Society to Reduce Cancer Care Disparities
The three-year initiative comes with $15 million in funding.
Novartis To Acquire MorphoSys AG
The agreement will strengthen Novartis’ oncology pipeline.
Global Cancer Burden Growing According to WHO Report
The report predicts a 77% increase in global cancer cases by 2050.
Novo Nordisk’s Parent Company to Acquire Catalent To Boost Supply of Wegovy
The drugmaker will directly acquire three finish-fill sites as part of the deal.
FDA Issues Warning of Contaminated Copycat Eyedrops
The agency issued the warning against three brands of unapproved eyedrops designed to look like an approved brand.
Novo Nordisk Increases Supply of Lower-Dose Wegovy to Meet Continued Demand
The company has struggled to supply the drug to patients due to overwhelming popularity.
Abbott Announces New High Protein Weight Loss Shake
The shake is designed to work with regular dieters and those taking weight loss medications.
Study Suggests That Alzheimer’s Disease is Transmissible in Rare Circumstances
Researchers noted the onset of symptoms in patients who were treated with contaminated HGH therapy.
EMA Grants Bersiporocin Orphan Drug Designation
The agency recognized the medication as a significant advancement for the treatment of IPF.
The Hospital of the Future and How Data, Digital, and AI Will Merge to Make Care Better: Q&A With Dr. Pierantonio Russo, Chief Medical Officer, EVERSANA
Dr. Russo discusses how modern innovations will shape the way hospitals operate in years to come.
Using AI to Improve Precision Medicine: Q&A With Dr. Kate Sasser, Chief Scientific Officer at Tempus
Sasser discusses how AI is directly helping with problems specific to precision and personalized medicine research.
Haleon Recalls Eight Lots of Robitussin Honey CF Max Day and Nighttime Due to Microbial Contamination
The company states that no adverse events have been reported due to the contamination as of yet.
Weeding Out Data Inconsistencies in CDL: Q&A With Roxy McCloskey, Thought Leader at SCIEX
McCloskey discusses the steps that drug developers can take to ensure better CLD outcomes in 2024.
Pusan National University Announces Potential Breakthrough for Muscle Regeneration Using Nanotech
According to the university, new nanotech scaffolding can be used to support tissue growth.
Building Awareness of Anti-Obesity Drugs: 2024 Trends
Experts weigh in on recent trends regarding weight loss medication and how they expect those trends to evolve in the coming year.
Eisai To Present New Data For Gastrointestinal Cancer Research at ASCO GI 2024
The data was collected during the LEAP clinical program, developed in partnership with Merck.
Regulatory Concerns for AI: 2024 Trends
As the technology becomes more ingrained within the Pharma industry’s processes, experts believe that regulation covering the use of AI is coming.
Precision Medicine’s Breakout Year: 2024 Trends
Investors may be attracted to precision medicine and gene therapy in the coming year due to a variety of reasons, including the treatments’ abilities to produce exact responses.
FDA Clears AnX Robotica’s NaviCam SB for Expanded Indications
The device can produce AI-assisted readings.
Dexcom Announces Preliminary and Unaudited Revenue For Fourth Quarter and Fiscal Year 2023
The company also announced that it has submitted its new glucose monitoring system to the FDA for approval.
Mucinex Survey Reveals Americans Only Feel Healthy For Half of Every Month
The survey is part of the brand’s new marketing campaign.
S&P Global Releases Healthcare Industry Outlook for 2024
While the industry as a whole still faces challenges, there are positive trends appearing for pharmaceutical and medical device companies.
Evaluate Acquires J+D Forecasting
Both companies are now under the Norstella umbrella.
HBA Announces 2024 Woman of the Year
The Healthcare Businesswomen’s Association will honor the recipient at an event later this year in New York City.
How Quantum Computing Trends Will Impact Pharma in 2024: Q&A With Erik Huestis, Partner at Foley Hoag
Huestis discusses the ways that quantum simulation and quantum systems can be used in areas such as drug discovery and the creation and protection of intellectual property in the life sciences industry.